Related Experiment Video
Updated: Jun 25, 2025

15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.2K
Applications of Artificial Intelligence for Pediatric Cancer Imaging.
Shashi B Singh1, Amir H Sarrami1, Sergios Gatidis1
1Department of Radiology, Division of Pediatric Radiology, Stanford University School of Medicine, 1201 Welch Rd, Stanford, CA 94305.
AJR. American Journal of Roentgenology
|May 29, 2024
Summary
Artificial intelligence (AI) shows promise in pediatric oncology imaging, but data scarcity and evolving technologies hinder its use. Overcoming these challenges through data sharing and transfer learning is key to improving outcomes for children with cancer.
Area of Science:
- Medical Imaging
- Pediatric Oncology
- Artificial Intelligence
Background:
- Artificial intelligence (AI) is revolutionizing adult medical imaging.
- Its application in pediatric oncology imaging is limited due to rare cancer incidence and insufficient data.
- Rapidly evolving imaging technologies further exacerbate data scarcity for training AI algorithms.
Purpose of the Study:
- To review current AI applications in pediatric cancer imaging.
- To identify challenges and opportunities for AI in this field.
- To explore strategies for enhancing AI clinical translation in pediatric oncology.
Main Methods:
- Review of current AI applications across medical image acquisition, processing, reconstruction, segmentation, diagnosis, staging, and treatment response monitoring.
- Analysis of impediments including anatomical diversity and nonstandardized protocols.
- Identification of opportunities such as accelerated low-dose imaging and automated metric generation.
Main Results:
- AI applications show promise in various aspects of pediatric cancer imaging.
- Significant impediments to clinical translation exist, including data scarcity and protocol variations.
- Leveraging reconstruction algorithms and transfer learning are identified as key opportunities.
Conclusions:
- Despite promising developments, clinical translation of AI in pediatric oncology is limited.
- Addressing data scarcity through multi-institutional sharing and transfer learning is crucial.
- Ethical data privacy practices are essential for advancing AI in rare pediatric cancers.

